OTCMKTS:ORINY Orion OYJ (ORINY) Stock Price, News & Analysis $43.02 0.00 (0.00%) As of 08/21/2026 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendEarningsNews and TrendsShort Interest About Orion OYJ Stock (OTCMKTS:ORINY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Orion OYJ alerts:Sign Up Key Stats Today's Range$43.02▼$43.0250-Day Range$38.54▼$43.0252-Week Range$30.89▼$43.22VolumeN/AAverage Volume20 shsMarket Capitalization$12.14 billionP/E Ratio17.70Dividend Yield0.88%Price TargetN/AConsensus RatingHold Company Overview Orion Corporation (Orion Oyj) is a Finland-based pharmaceutical company engaged in the research, development, manufacture and marketing of human and veterinary medicines as well as diagnostic tests. The company’s core therapeutic areas include central nervous system disorders, oncology and respiratory diseases, and it offers both proprietary and generic products. Orion’s product range spans from small-molecule drugs and active pharmaceutical ingredients to radiodiagnostic imaging agents and line extensions developed through in-house research. Since its founding in 1917 in Helsinki, Orion has grown into an integrated pharmaceuticals business with state-of-the-art manufacturing facilities in Finland and France. The company’s R&D organization focuses on novel chemical entities and life-cycle management of existing products, supported by a network of research partnerships and licensing agreements. In addition to human healthcare, Orion Diagnostica develops and distributes immunoassays and point-of-care tests for clinical and veterinary diagnostics. Orion serves markets across Europe, the Nordic countries and selected regions in Asia and Latin America, leveraging both direct sales operations and partner networks. The company maintains strategic alliances to expand its geographic reach and enhance market access for its specialty products. Orion’s customer base includes hospitals, pharmacies and healthcare professionals, reflecting its long-established presence in the pharmaceutical industry.AI Generated. May Contain Errors. Read More Receive ORINY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Orion OYJ and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ORINY Stock News HeadlinesOrion OyjJuly 12, 2026 | fool.comOrion Oyj Record 2025 Results Put Board Changes And Valuation In FocusFebruary 15, 2026 | finance.yahoo.comThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's pullback from highs above 4000 an ounce. Yet top junior mining assets remain priced as if gold were still stuck near 1800 an ounce, a gap analyst Garrett Goggin calls the Golden Anomaly. With record cash on hand, majors may soon be forced to buy juniors to secure future production.August 24 at 1:00 AM | Golden Portfolio (Ad)Does Orion Oyj (HLSE:ORNBV) Dividend Hike Clarify Its Oncology-Pivot Capital Allocation Strategy?February 14, 2026 | finance.yahoo.comOrion Oyj (ORINY) Q4 2025 Earnings Call Highlights: Record Growth and Strategic DevelopmentsFebruary 12, 2026 | finance.yahoo.comAssessing Orion Oyj (HLSE:ORNBV) Valuation After A Strong 1 Year Shareholder ReturnFebruary 7, 2026 | finance.yahoo.comOrion publishes Financial Statement Release for 2025 and holds a webcast on 12 February 2026January 30, 2026 | uk.finance.yahoo.comAssessing Whether Orion Oyj (HLSE:ORNBV) Justifies Its Premium P/E After Strong Recent ReturnsJanuary 15, 2026 | finance.yahoo.comSee More Headlines ORINY Stock Analysis - Frequently Asked Questions How have ORINY shares performed this year? Orion OYJ's stock was trading at $36.8425 at the beginning of the year. Since then, ORINY shares have increased by 16.8% and is now trading at $43.0160. How were Orion OYJ's earnings last quarter? Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) issued its quarterly earnings data on Friday, July, 17th. The company reported $0.58 earnings per share for the quarter. The business had revenue of $606.38 million for the quarter. Orion OYJ had a net margin of 28.52% and a trailing twelve-month return on equity of 50.37%. How do I buy shares of Orion OYJ? Shares of ORINY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings7/17/2026Today8/24/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:ORINY Previous SymbolNASDAQ:ORINY CIKN/A Webwww.orion.fi Phone358 10 4261FaxN/AEmployees4,029Year FoundedN/AProfitability EPS (Trailing Twelve Months)$2.43 Trailing P/E Ratio17.70 Forward P/E RatioN/A P/E GrowthN/ANet Income$566.04 million Net Margins28.52% Pretax Margin35.39% Return on Equity50.37% Return on Assets30.65% Debt Debt-to-Equity Ratio0.08 Current Ratio2.64 Quick Ratio1.48 Sales & Book Value Annual Sales$2.14 billion Price / Sales5.68 Cash Flow$2.23 per share Price / Cash Flow19.27 Book Value$5.15 per share Price / Book8.35Miscellaneous Outstanding Shares282,270,000Free FloatN/AMarket Cap$12.14 billion OptionableNot Optionable Beta0.07 Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (OTCMKTS:ORINY) was last updated on 8/24/2026 by MarketBeat.com Staff. From Our PartnersThe dollar reset no one told you aboutPorter Stansberry says a dollar reset is underway - one that has happened only once before in America's 250-ye...Porter & Company | SponsoredThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredA $382 trillion migration and the position no one is talking aboutTrump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money ne...Awesomely | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | Sponsored"Second Wave” Hitting Iran Soon? Wall Street Issues WarningAnalysts at Goldman Sachs and Morgan Stanley are warning that a quiet domestic threat - unrelated to overseas ...TradeSmith | SponsoredElon Musk’s Hushed FCC Filing. Sept 25th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...Paradigm Press | SponsoredGold majors have a big problemNewmont spent 15 billion dollars acquiring Newcrest in 2023, the largest deal in gold mining history. Yet prod...Golden Portfolio | SponsoredGet this “Fed ticker” before September 16Barron's ranked Larry Benedict's former hedge fund among the top 1% in the world. He went 20 straight years wi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orion OYJ Unsponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Orion OYJ With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
